Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur M Friedlander

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|July 3, 2013
3-substituted indole inhibitors against Francisella tularensis FabI identified by structure-based virtual screeningXin Hu, Jaimee R Compton, Mohamed Diwan M Abdulhameed, et al.
The Journal of Infectious Diseases|December 23, 2008
A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibioticsNicholas J Vietri, Bret K Purcell, Steven A Tobery, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2006
Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthraxNicholas J Vietri, Bret K Purcell, James V Lawler, et al.
Journal of Innate Immunity|April 9, 2010
ClpX contributes to innate defense peptide resistance and virulence phenotypes of Bacillus anthracisShauna M McGillivray, Celia M Ebrahimi, Nathan Fisher, et al.
Emerging Infectious Diseases|January 26, 2019
Formaldehyde and Glutaraldehyde Inactivation of Bacterial Tier 1 Select Agents in TissuesJennifer Chua, Joel A Bozue, Christopher P Klimko, et al.
Genome Announcements|February 14, 2013
Genome Sequence of the Attenuated Carbosap Vaccine Strain of Bacillus anthracisRobin Harrington, Brian D Ondov, Diana Radune, et al.
JAMA|May 1, 2002
Anthrax as a biological weapon, 2002: updated recommendations for managementThomas V Inglesby, Tara O'Toole, Donald A Henderson, et al.
The Journal of Biological Chemistry|July 20, 2011
Improvement of a potential anthrax therapeutic by computational protein designSean J Wu, Christopher B Eiben, John H Carra, et al.
The Journal of Infectious Diseases|July 23, 2020
Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With CiprofloxacinNicholas J Vietri, Steven A Tobery, Donald J Chabot, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2005
The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infectionYusheng Xiong, Judyann Wiltsie, Andrea Woods, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|July 3, 2013
3-substituted indole inhibitors against Francisella tularensis FabI identified by structure-based virtual screeningXin Hu, Jaimee R Compton, Mohamed Diwan M Abdulhameed, et al.
The Journal of Infectious Diseases|December 23, 2008
A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibioticsNicholas J Vietri, Bret K Purcell, Steven A Tobery, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2006
Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthraxNicholas J Vietri, Bret K Purcell, James V Lawler, et al.
Journal of Innate Immunity|April 9, 2010
ClpX contributes to innate defense peptide resistance and virulence phenotypes of Bacillus anthracisShauna M McGillivray, Celia M Ebrahimi, Nathan Fisher, et al.
Emerging Infectious Diseases|January 26, 2019
Formaldehyde and Glutaraldehyde Inactivation of Bacterial Tier 1 Select Agents in TissuesJennifer Chua, Joel A Bozue, Christopher P Klimko, et al.
Genome Announcements|February 14, 2013
Genome Sequence of the Attenuated Carbosap Vaccine Strain of Bacillus anthracisRobin Harrington, Brian D Ondov, Diana Radune, et al.
JAMA|May 1, 2002
Anthrax as a biological weapon, 2002: updated recommendations for managementThomas V Inglesby, Tara O'Toole, Donald A Henderson, et al.
The Journal of Biological Chemistry|July 20, 2011
Improvement of a potential anthrax therapeutic by computational protein designSean J Wu, Christopher B Eiben, John H Carra, et al.
The Journal of Infectious Diseases|July 23, 2020
Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With CiprofloxacinNicholas J Vietri, Steven A Tobery, Donald J Chabot, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2005
The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infectionYusheng Xiong, Judyann Wiltsie, Andrea Woods, et al.
Pageof 6